Abstract: Combinatorial therapeutic systems can include a systemic, centrally and peripherally acting analgesics and an artificial sensory experience. Methods for treating and/or mitigating pain can include receiving a systemic, centrally and peripherally acting analgesic and an artificial sensory experience. The analgesic can include oliceridine or bupivacaine-meloxicam. The artificial sensory experience can include one or more of 2D/3D/4D artificial sensory experiences, holography, augmented reality, virtual reality, and/or mixed reality. In some instances, the virtual reality is virtual reality neuropsychological therapy or virtual reality distraction therapy.

Abstract: Combinatorial therapeutic systems can include an artificial sensory experience and a therapeutically effective amount of an analgesic selected from tapentadol or difelikefalin (CR845). Methods for treating and/or mitigating pain can include at least (i) receiving a therapeutic dose of an analgesic selected from tapentadol or difelikefalin (CR845) and (ii) receiving an artificial sensory experience. The artificial sensory experience can include one or more of 2D/3D/4D artificial sensory experiences, holography, augmented reality, virtual reality, and/or mixed reality. In some instances, the artificial sensory experience is virtual reality neuropsychological therapy or virtual reality distraction therapy.

Abstract: Embodiments are directed to identifying and measuring bodily states and feedback systems. A computer system initializes a tracking and measuring device to generate patient data related to a bodily state or feedback system of a patient. The computer system gathers the patient data using the initialized tracking and measuring device, and identifies a baseline parameter used to determine a baseline state relative to the gathered patient data. The computer system further gathers additional patient data using the initialized tracking and measuring device and compares the additional gathered patient data to the identified baseline parameter. Then, if the additional gathered patient data differs from the baseline state by a specified threshold amount, the computer system determines that a change in the patient's bodily state or feedback system has occurred and/or determines the amount of change in the bodily state or feedback systems that has occurred.

Abstract: Systems and methods are provided for generating dynamic representations of symptoms and symptom alleviation.

Abstract: Combinatorial therapeutic systems can include an artificial sensory experience and a therapeutically effective amount of an analgesic selected from tapentadol or difelikefalin (CR845). Methods for treating and/or mitigating pain can include at least (i) receiving a therapeutic dose of an analgesic selected from tapentadol or difelikefalin (CR845) and (ii) receiving an artificial sensory experience. The artificial sensory experience can include one or more of 2D/3D/4D artificial sensory experiences, holography, augmented reality, virtual reality, and/or mixed reality. In some instances, the artificial sensory experience is virtual reality neuropsychological therapy or virtual reality distraction therapy.

Abstract: Computer systems and methods can include generating a multidimensional sensory environment using an immersive technology, creating a first digital model that includes a visual representation of an emotional, psychological, or somatosensory user experience or aspect of the user experience, receiving a description of an extra-visual sensory signal, layering the extra-visual sensory signal onto the first digital model such that the extra-visual sensory signal is configured to be produced by a sensory device, and producing a corporealized form of the user experience or aspect of the user experience in the multidimensional sensory environment by at least displaying the visual representation of the first digital model in the multidimensional sensory environment via the immersive technology and producing the extra-visual sensory signal associated with the first digital model at the sensory device. The corporealized user experience can be affected to increase user health and/or performance.

Abstract: Embodiments are directed to identifying and measuring bodily states and feedback systems. A computer system initializes a tracking and measuring device to generate patient data related to a bodily state or feedback system of a patient. The computer system gathers the patient data using the initialized tracking and measuring device, and identifies a baseline parameter used to determine a baseline state relative to the gathered patient data. The computer system further gathers additional patient data using the initialized tracking and measuring device and compares the additional gathered patient data to the identified baseline parameter. Then, if the additional gathered patient data differs from the baseline state by a specified threshold amount, the computer system determines that a change in the patient's bodily state or feedback system has occurred and/or determines the amount of change in the bodily state or feedback systems that has occurred.

Abstract: Systems and methods are provided for generating dynamic representations of symptoms and symptom alleviation.

Abstract: Systems and methods are provided for generating dynamic representations of symptoms and symptom alleviation.

Abstract: Systems and methods are provided for generating dynamic representations of symptoms and symptom alleviation.